Tag Archives: Neelie Kroes
Europe: Not Out of the Antitrust Woods Yet
Guest blog from Pharm Exec Europe’s Brussels correspondent, Reflector.
The new year has started with a grim reminder that last year’s heat over competition in the European pharmaceutical sector has not been dissipated by the winter’s frosts. Before January was a week old, the European Commission (EC) announced that it had opened a formal antitrust [...]
Posted in Europe, Global, Guest Blog, Regulatory Also tagged antitrust, Competition, European Commission, European Union, Lundbeck, Regulatory Leave a comment
The EC Admonishes European Pharma, European Pharma Celebrates
Despite the rhetoric, the climax of the European Commission’s antitrust investigations — instigated with dawn raids on the major pharma companies by EC Competition Commissioner Neelie Kroes last year — has been more of a whimper than a bang.
Pharm Exec Europe’s EU correspondent Reflector goes so far as to say “Big Pharma is not opening [...]
Posted in Global, Regulatory Also tagged anti-competitive, antitrust, Brussels, EC, European Commission, European Union, generics, investigations, Regulatory Leave a comment
Pharma Accused of Keeping Good Generics Down
Image via Wikipedia
The European Commission has accused the pharmaceutical industry of delaying the entry of generic drugs to the market. As a result, it intends to step up its scrutiny of the sector under EU antitrust law. “We must have more competition and less red tape in pharmaceuticals,” claimed Competition Commissioner Neelie Kroes. “The inquiry [...]
Posted in Global, News Also tagged business, Competition Commissioner Neelie Kroes, EU, European Commission, European Union, Generic drug, pharmaceutical industry 1 Comment

"Data is the New Oil": Open Access to Sweep Europe?